Warning letter
Icon Laboratories: warning letter of Feb 4, 2003
FDA warning letter UCM147292 · Florida District Office
Key facts
| Reference number | UCM147292 |
|---|---|
| Company | Icon Laboratories |
| Subject | Over-the Counter Drug/CGMP for Finished Pharmaceuticals/Adulterated |
| Issue date | Feb 4, 2003 |
| Posted date | Feb 4, 2003 |
| Issuing office | Florida District Office |
| Product type | Drugs |
| CFR sections cited | 211 |
| Country | 3 |
| Inspection city | Ormond Beach |
| Inspection ZIP | 32176-3203 |
| Inspection start date | Feb 5, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: